(Q44797573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

0 references

0 references

inflammatory bowel diseases

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Natalia Battista

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Giuseppe Astarita

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Alessandro Vanoli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Enrico Dainese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Gino R Corazza

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

P Biancheri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

C Rapino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

L Rovedatti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Guerci

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

D Piomelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

S L F Pender

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

T T MacDonald

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Maccarrone

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

6 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

574-583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21471961%20AND%20SRC:MED&resulttype=core&format=json

The immunological and genetic basis of inflammatory bowel disease

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Immunity, inflammation, and allergy in the gut.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoids cool the intestine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Endocannabinoid biosynthesis and inactivation, from simple to complex

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Endocannabinoid chemical biology: a tool for the development of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Enzymological studies on the biosynthesis of N-acylethanolamines

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoids and the gut: new developments and emerging concepts

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoids and the immune system: an overview

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

The endogenous cannabinoid system protects against colonic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Endocannabinoid overactivity and intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoid-based drugs as anti-inflammatory therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Targeting the CB2 receptor for immune modulation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Fibrogenesis in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Myofibroblasts. II. Intestinal subepithelial myofibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021

Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.18

7 January 2021